The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

10.1016/j.trci.2018.12.001

Saved in:

Bibliographic Details
Main Authors:	Chen, C.L.H., Sharma, P.R., Tan, B.Y., Low, C., Venketasubramanian, N.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	Elsevier Inc 2021
Subjects:	Alzheimer's disease Clinical trial Disease progression MLC901 Neuroaid II
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/212354
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-212354
record_format	dspace
spelling	sg-nus-scholar.10635-2123542024-04-04T04:21:31Z The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial Chen, C.L.H. Sharma, P.R. Tan, B.Y. Low, C. Venketasubramanian, N. PHARMACOLOGY Alzheimer's disease Clinical trial Disease progression MLC901 Neuroaid II 10.1016/j.trci.2018.12.001 Alzheimer's and Dementia: Translational Research and Clinical Interventions 5 38-45 2021-12-29T04:38:42Z 2021-12-29T04:38:42Z 2019 Article Chen, C.L.H., Sharma, P.R., Tan, B.Y., Low, C., Venketasubramanian, N. (2019). The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial. Alzheimer's and Dementia: Translational Research and Clinical Interventions 5 : 38-45. ScholarBank@NUS Repository. https://doi.org/10.1016/j.trci.2018.12.001 23528737 https://scholarbank.nus.edu.sg/handle/10635/212354 Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/ Elsevier Inc Scopus OA2019
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Alzheimer's disease Clinical trial Disease progression MLC901 Neuroaid II
spellingShingle	Alzheimer's disease Clinical trial Disease progression MLC901 Neuroaid II Chen, C.L.H. Sharma, P.R. Tan, B.Y. Low, C. Venketasubramanian, N. The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
description	10.1016/j.trci.2018.12.001
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Chen, C.L.H. Sharma, P.R. Tan, B.Y. Low, C. Venketasubramanian, N.
format	Article
author	Chen, C.L.H. Sharma, P.R. Tan, B.Y. Low, C. Venketasubramanian, N.
author_sort	Chen, C.L.H.
title	The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
title_short	The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
title_full	The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
title_fullStr	The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
title_full_unstemmed	The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
title_sort	alzheimer's disease therapy with neuroaid (athene) study protocol: assessing the safety and efficacy of neuroaid ii (mlc901) in patients with mild-to-moderate alzheimer's disease stable on cholinesterase inhibitors or memantine—a randomized, double-blind, placebo-controlled trial
publisher	Elsevier Inc
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/212354
_version_	1800915271792197632

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

Similar Items